Similar articles

• The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.

  Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C. Brusamolino E, et al. Haematologica. 1998 Sep;83(9):812-23. Haematologica. 1998. PMID: 9825578
• MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.

  Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M. Gobbi PG, et al. Clin Cancer Res. 2006 Jan 15;12(2):529-35. doi: 10.1158/1078-0432.CCR-05-1707. Clin Cancer Res. 2006. PMID: 16428496 Clinical Trial.
• Hodgkin's disease, splenectomy and secondary leukemia.

  Centurioni R, Brianzoni F, Leoni P, Danieli G. Centurioni R, et al. Haematologica. 1993 Jul-Aug;78(4):258-9. Haematologica. 1993. PMID: 8294062 No abstract available.
• Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.

  McClain KL, Heise R, Day DL, Lee CK, Woods WG, Aeppli D. McClain KL, et al. Am J Pediatr Hematol Oncol. 1990 Summer;12(2):147-54. Am J Pediatr Hematol Oncol. 1990. PMID: 1696073 Review.
• Hodgkin's disease: controversies and challenges for the future.

  Tura S, Canellos G, Goldstone A, Longo D, McMillan A, Urba W, Zinzani PL. Tura S, et al. Haematologica. 1991 Jul-Aug;76(4):263-79. Haematologica. 1991. PMID: 1724436 Review. No abstract available.